Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evidence for SIRT1 Mediated HMGB1 Release From Kidney Cells in the Early Stages of Hemorrhagic Shock

NCT03535441 is registered in ClinicalTrials.gov with Xingui Dai as lead sponsor.

NCT NCT03535441
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03535441 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evidence for SIRT1 Mediated HMGB1 Release From Kidney Cells in the Early Stages of Hemorrhagic Shock
Lead sponsor
Xingui Dai
Phase
Observational
Overall status
Completed
Start date
May 17, 2017
Completion date
May 11, 2018
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adult disease, hemorrhagic shock, intensive care unit